Published in Ann Thorac Surg on February 01, 1991
Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J (1994) 0.84
Passive infusion: a simple delivery method for retrograde cardioplegia. Tex Heart Inst J (2004) 0.75
Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg (1991) 1.73
Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg (1984) 2.07
Tranexamic acid significantly reduces blood loss associated with coronary revascularization. Ann Thorac Surg (1995) 1.44
Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation (1999) 1.43
Postischemic deterioration of sarcoplasmic reticulum: warm versus cold blood cardioplegia. Ann Thorac Surg (1993) 1.39
Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ Res (1990) 1.39
Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun (1987) 1.29
Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol (2001) 1.29
Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res (1999) 1.28
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
Mediastinitis following open-heart surgery. Review of two years' experience. Arch Surg (1973) 1.19
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Postpneumonectomy esophageal fistula: successful one-stage repair. J Thorac Cardiovasc Surg (1970) 1.16
Esophagogastrostomy. Analysis of 55 cases. J Thorac Cardiovasc Surg (1975) 1.15
Myocardial protection with red wine extract. J Cardiovasc Pharmacol (2000) 1.14
Epicardial activation of the intact human heart without conduction defect. Circulation (1979) 1.13
The long-term influence of coronary bypass grafts on myocardial infarction and survival. Ann Surg (1974) 1.13
Aneurysm of aberrant right subclavian artery. Rare cause of superior mediastinal tumor. N Y State J Med (1973) 1.10
Thoracic aortic dissection following cannulation for perfusion. Ann Thorac Surg (1974) 1.10
Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res (1993) 1.05
Phrenic nerve paresis associated with the use of iced slush and the cooling jacket for topical hypothermia. J Thorac Cardiovasc Surg (1985) 1.02
Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation (1997) 1.00
Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol (1986) 0.98
Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg (2000) 0.97
Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res (1995) 0.95
The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg (1999) 0.95
Oxygen free radical signaling in ischemic preconditioning. Ann N Y Acad Sci (1999) 0.95
The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res (1996) 0.94
Experience with open mitral commissurotomy in 100 consecutive patients. Surgery (1974) 0.94
Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence. Ann Surg (1973) 0.94
Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation (1993) 0.92
Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol (1995) 0.91
L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg (1995) 0.91
Complications of ventriculoatrial shunting for hydrocephalus requiring cardiac operation. Ann Thorac Surg (1969) 0.90
Transatrial repair of postinfarction posterior ventricular septal defect. Ann Thorac Surg (1987) 0.90
Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation (1996) 0.90
Coronary artery bypass with freeze-preserved saphenous vein allografts. J Thorac Cardiovasc Surg (1976) 0.90
Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection. Ann N Y Acad Sci (1998) 0.89
Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation (2000) 0.89
Blood conservation for myocardial revascularization. Is it cost effective? J Thorac Cardiovasc Surg (1987) 0.89
Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures. J Thorac Cardiovasc Surg (1983) 0.89
Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol (1986) 0.88
Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem (1996) 0.88
Safety of prolonged ischemic arrest using hypothermic cardioplegia. J Thorac Cardiovasc Surg (1980) 0.88
Use of extrafascially harvested radial artery for coronary artery revascularization: technical considerations. J Card Surg (2000) 0.88
Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation (2000) 0.88
Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem (1998) 0.88
Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol (1991) 0.87
Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. J Mol Cell Cardiol (1986) 0.87
Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg (1995) 0.87
Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation (1993) 0.87
Traumatic ventricular septal defect following closed-chest massage: a new approach to closure. Ann Thorac Surg (1984) 0.86
Effects of free radicals on the fluidity of myocardial membranes. Free Radic Res Commun (1989) 0.86
Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr (1993) 0.86
Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther (1993) 0.86
Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther (1998) 0.85
Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass. Circulation (1995) 0.85
Nonthrombogenic aortic and vena caval bypass using heparin-coated tubes. Am J Surg (1974) 0.85
Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. J Thorac Cardiovasc Surg (1986) 0.84
Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther (1995) 0.84
The role of protein kinase in C ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol (1996) 0.83
Mycotic infections on prosthetic and homograft heart valves: report of the first case of endocarditis caused by Hormodendrum dermatitidis. Ann Surg (1971) 0.83
Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. J Thorac Cardiovasc Surg (1986) 0.83
Routine operative arteriography following vascular reconstruction. Surg Gynecol Obstet (1969) 0.83
Late complications of intraoperative coronary artery perfusion. Circulation (1973) 0.83
Disseminated intravascular coagulation following extracorporeal circulation. J Thorac Cardiovasc Surg (1972) 0.83
Aberrant right subclavian artery aneurysm: a rare cause of a superior mediastinal tumor. Chest (1972) 0.82
Postnatal developmental profiles of antioxidant enzymes in heart. Ann N Y Acad Sci (1996) 0.82
Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart. Circ Res (1988) 0.82
Effect of normothermic blood cardioplegia on postoperative conduction abnormalities and supraventricular arrhythmias. Circulation (1992) 0.82
Rebound vasospasm after coronary revascularization in association with calcium antagonist withdrawal. Ann Thorac Surg (1984) 0.82
Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol (1994) 0.82
New technique for repair of posterior left ventricular rupture. J Thorac Cardiovasc Surg (1979) 0.82
Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-reperfused myocardium. Eur Heart J (1990) 0.82
Ginkgo biloba extract (EGb 761) improves postischemic function in isolated preconditioned working rat hearts. Coron Artery Dis (1994) 0.81
Emergency cardiopulmonary bypass in the cardiac surgical unit can be a lifesaving measure in postoperative cardiac arrest. Circulation (1994) 0.81
Does the type of venous drainage or cardioplegia affect postoperative conduction and atrial arrhythmias? Circulation (1985) 0.81
Developmental profiles of protective mechanisms of heart against peroxidative injury. Basic Res Cardiol (1987) 0.81
Myocardial injury associated with potassium arrest. Ann Thorac Surg (1976) 0.81
Signal transduction pathway leading to Hsp27 and Hsp70 gene expression during myocardial adaptation to stress. Ann N Y Acad Sci (1998) 0.81
Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther (1994) 0.81
Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network. Gene Ther (2010) 0.81
Role of phospholipases A2 and C in myocardial ischemic reperfusion injury. Am J Physiol (1991) 0.81
Nitric oxide signaling in ischemic heart. Cardiovasc Res (1995) 0.80
Oxygen-derived free radicals and hemolysis during open heart surgery. Mol Cell Biochem (1992) 0.79
Metabolic enhancement of myocardial preservation during cardioplegic arrest. J Thorac Cardiovasc Surg (1986) 0.79
Tricuspid annuloplasty. Five and one-half years' experience with 78 patients. J Thorac Cardiovasc Surg (1974) 0.79
The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest. Surgery (1979) 0.79
Possible physiological role of myocardial fatty acid binding protein in phospholipid biosynthesis. J Lipid Mediat (1992) 0.79
Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Biochem Pharmacol (1993) 0.79
The significance of coronary arterial stenosis during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1975) 0.79
Preconditioning potentiates molecular signaling for myocardial adaptation to ischemia. Ann N Y Acad Sci (1996) 0.79
Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion. Circulation (1996) 0.79
Perioperative morbidity in diabetics requiring coronary artery bypass surgery. Ann Thorac Surg (1988) 0.78
Effect of superoxide dismutase and catalase on myocardial energy metabolism during ischemia and reperfusion. Clin Physiol Biochem (1986) 0.78
Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors. Cardiovasc Drugs Ther (1992) 0.78
Improvement of ischemia-reperfusion-induced myocardial dysfunction by modulating calcium-overload using a novel, specific calmodulin antagonist, CGS 9343B. Biochem Pharmacol (1989) 0.78
Operative management of tricuspid regurgitation. Circulation (1976) 0.78
Shoulder pain as a presenting complaint in upper lobe bronchogenic carcinoma: report of 21 cases. Conn Med (1966) 0.78
Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg (1995) 0.78
Presence of angiographic coronary collaterals predicts myocardial recovery after coronary bypass surgery in patients with severe left ventricular dysfunction. Circulation (1998) 0.78